Below is a current listing of all open clinical trials at Howard University Cancer Center. For more information, please contact Theresa Vaughn at 202-806-7037.

Blood Cancers

Randomized Phase III Trial of Consolidation Therapy with Bortezomib (Velcade) - Lenalidomide (Revlimid) - Dexamethasone (VRD) versus Bortezomib (Velcade) - Dexamethasone (VD) for Patients with Multiple Myeloma Who Have Completed Dexamethasone Based Induction Regimen (E1A05)
Principal Investigator: Patricia Oneal, MD

Breast Cancer

DC City-Wide Patient Navigation Research Program
Principal Investigator: Wayne A. I. Frederick, MD

Program for the Assessment of Clinical Cancer Tests (PACCT-1); Trail Assigning Individualized Options for Treatment: The TAILORx Trial (PACCT-1)
Principal Investigator: Melvin Gaskins, MD

A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer (E5103)
Principal Investigator: Anita Aggarwal, DO, PhD

A Randomized Phase III Double-Blind Placebo-Controlled Trial of First-Line Chemotherapy and Trastuzumab with or without Bevacizumab for Patients with Her-2/NEU Over-expressing Metastatic Breast Cancer (E1105)
Principal Investigator: Sara Horton, MD

Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer
Principal Investigator: Sara Horton, MD

Lung Cancer

Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIB/IV Non-Small Cell Lung Cancer (CALGB 30607)
Principal Investigator: Gladys Onojobi, MD

Prostate Cancer

A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone (CALGB 90202)
Principal Investigator: Adriana Medina, MD

Phase III Study of Docetaxel and Atrasentan versus Docetaxel and Placebo for Patients with Advanced Hormone Refractory Prostate Cancer (S0421)
Principal Investigator: Adriana Medina, MD

Rectal Cancer

A Phase III Prospective Randomized Trial Comparing Laparoscopic-assisted Resection Versus Open Resection for Rectal Cancer (Z6051)
Principal Investigator: Wayne A. I. Frederick, MD

All Cancers

Narrowing the Gap in Adjuvent Therapy
Principal Investigator: Anita Aggarwal, DO, PhD
Co-Principal Investigator: Sarah Horton, MD